IPO Guru
Upcoming Opens 21 Oct 2026

Paras Healthcare IPO GMP Today – Live Grey Market Premium

As of 14 Oct 2026, 11:24 PM IST, Paras Healthcare IPO GMP is ₹83. Kostak: not available. Subject to Sauda: not available.

Paras Healthcare IPO is scheduled to open for subscription on October 21, 2026. The public issue aims to raise around ₹1450 Cr. and is offered in a price band of TBA per share, with a market lot of TBA shares. The day-wise GMP trend is below.

Abhishek Vohera, Founder of IPO Guru Researched & reviewed by Abhishek Vohera, Founder, IPO Guru Last updated Figures sourced from the RHP, BSE & NSE

GMP trend

Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 14 Oct, 11:24 PM IST.

Peak GMP
₹83
14 Oct 2026
Lowest GMP
₹83
14 Oct 2026
Direction
— stable
Latest day vs the day before

Day-wise GMP

The last reading of each day, newest first. Arrows compare with the previous day.

Date GMP ↑↓ % Kostak Sub. Sauda
14 Oct 2026 ₹ 83 — -- — —

Paras Healthcare IPO dates

Key dates from opening to listing. Today is 14 October.

Key dates Opens soon
  1. Open 21 Oct 2026
  2. Close 23 Oct 2026
  3. Allotment TBA
  4. Refund/credit TBA
  5. Listing 28 Oct 2026

Paras Healthcare IPO expected listing price

Upper price band plus today's grey market premium.

Issue price (upper band)TBA
Current GMP₹ 83
Listing date28 Oct, 2026
GMP-based listing estimate Not yet available

Disclaimer: The listing price estimate above is based purely on the current grey market premium (GMP) and is not a guaranteed prediction. GMP is an unofficial, unregulated indicator and can change significantly in the 24–48 hours before listing. Do not make investment decisions based solely on GMP.

Is Paras Healthcare IPO GMP reliable?

Grey market premium for Paras Healthcare IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:

  • 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
  • 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
  • 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
  • 04Cross-check before acting: Review the Paras Healthcare IPO full review for a fundamentals-based assessment before making any grey market trades.

Paras Healthcare IPO Kostak rate explained

Two ways the grey market trades an IPO application before listing.

Kostak
Not available

The Kostak rate for Paras Healthcare IPO is not available. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.

Subject to Sauda
Not available

The Subject to Sauda price is not available. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.

Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.

About Paras Healthcare IPO

Paras Healthcare Limited is a clinical specialty-led hospital platform that provides tertiary and quaternary healthcare through a network of eight hospitals with an aggregate capacity of 2,211 beds as on 31 March 2026. It operates under the Paras Health brand and is based at Paras Twin Towers, Golf Course Road, Sector 54, Gurugram, Haryana. Its critical care infrastructure includes organ and condition-specific ICUs, with 559 ICU beds as on 31 March 2026, up from 425 beds in FY2024. The hospitals employed 1,011 doctors and 1,665 nurses on the same date.

The hospitals are spread over five states and one union territory. They are in Gurugram and Panchkula in Haryana, Patna and Darbhanga in Bihar, Kanpur in Uttar Pradesh, Udaipur in Rajasthan, Ranchi in Jharkhand and Srinagar in Jammu and Kashmir. The Gurugram hospital has run for 20 years and the Patna hospital for 12 years, while the newest units at Srinagar and Kanpur have run for three years and two years. Of the eight, four are super-specialty tertiary care hospitals and four are multi-specialty tertiary care hospitals. Six of the eight run on leased premises, five through revenue share arrangements and long-term leases and one under a public private partnership.

The business is reported as a single healthcare services segment in a single geography. Work is concentrated in what the company calls CONGOR specialties, meaning cardiac sciences, oncology, neuro sciences, gastro sciences, orthopedics and sports injury, and renal sciences. Together these gave 74.70% of FY2026 revenue from operations, led by oncology at 21.63%, neuro sciences at 13.03% and cardiac sciences at 12.78%. Hospitals outside Gurugram, which the company counts as tier 2 cities, gave 68.18% of FY2026 revenue against 62.35% in FY2024.

Operating metrics improved in FY2026. Operational beds rose to 1,502 from 1,465, the bed occupancy rate rose to 61.75% from 50.78%, and occupied bed days rose to 3,38,321 from 2,68,927. In-patient volumes were 1,15,496 and out-patient volumes 7,78,707 in FY2026, against 81,047 and 5,69,139 in FY2024, and the hospitals performed 39,687 surgeries. Average revenue per occupied bed was Rs 47,397.82 per day in FY2026, with the Gurugram hospital at Rs 70,925.76 per day and the Darbhanga hospital at Rs 19,980.75 per day. Average length of stay was 2.93 days.

Payments come from three sources. Government schemes and public sector undertakings accounted for 41.28% of FY2026 revenue, self pay patients 33.88% and insurance and third party administrators 24.84%. In FY2024 the same shares were 29.76%, 40.63% and 29.61%. The promoter is Dr. Dharminder Kumar Nagar, the Managing Director, who has been with the company since 2003 and has over 22 years of experience in healthcare. He holds an MBBS from the University of Mysore and a master of philosophy in hospital and health systems management from BITS Pilani.

View full IPO details →

Frequently asked

What is the GMP of Paras Healthcare IPO?

The current Grey Market Premium (GMP) of Paras Healthcare IPO is ₹ 83.

What is the Kostak Price of Paras Healthcare IPO?

Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Paras Healthcare IPO is not available.

What is the Subject to Sauda Price of Paras Healthcare IPO?

Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.

What is the expected listing price of Paras Healthcare IPO based on GMP?

The listing price estimate is not yet available as GMP has not been established for Paras Healthcare IPO. Check back closer to the subscription date.

Is the GMP of Paras Healthcare IPO increasing or decreasing?

The GMP of Paras Healthcare IPO is currently stable. Track the day-wise GMP table above for the latest movement.

Explore Paras Healthcare IPO further

The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.

Opens 21 October 2026

GMP is a mood, not a forecast.

IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.

Join the WhatsApp channel All live IPO GMP

Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.

GMP
₹ 83
Kostak
—
Est. listing
TBA
Full IPO details